WallStreetZenWallStreetZen

NASDAQ: AGIO
Agios Pharmaceuticals Inc Stock Ownership - Who owns Agios Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Agios Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David ScaddenDirector2025-11-12200$43.84
$8.77kSell
David ScaddenDirector2025-11-12200$18.09
$3.62kBuy
Sarah GheuensChief Medical Officer2025-11-112,454$43.78
$107.44kSell
Sarah GheuensChief Medical Officer2025-11-112,454$25.01
$61.37kBuy
Sarah GheuensChief Medical Officer2025-10-30200$43.81
$8.76kSell
Sarah GheuensChief Medical Officer2025-10-30200$25.01
$5.00kBuy
Sarah GheuensChief Medical Officer2025-10-273,302$25.01
$82.58kBuy
Sarah GheuensChief Medical Officer2025-10-273,302$43.92
$145.02kSell
David ScaddenDirector2025-10-08200$18.09
$3.62kBuy
David ScaddenDirector2025-10-08200$41.00
$8.20kSell

1 of 5

AGIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AGIO insiders and whales buy or sell their stock.

AGIO Shareholders

What type of owners hold Agios Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Celgene European Investment Co LLC10.06%5,867,279$160.00MInsider
Farallon Capital Management LLC9.91%5,781,066$157.65MInstitution
Vanguard Group Inc9.61%5,604,876$152.84MInstitution
Blackrock Inc7.80%4,545,738$123.96MInstitution
Robert Nelsen6.81%3,969,968$108.26MInsider
Bellevue Group Ag6.37%3,714,736$101.30MInstitution
Arch Venture Fund VII LP5.30%3,088,590$84.23MInsider
Erste Asset Management Gmbh4.74%2,764,900$75.40MInstitution
Paradigm Biocapital Advisors LP4.58%2,673,555$72.91MInstitution
Celgene Corp4.26%2,486,157$67.80MInsider

1 of 3

AGIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AGIO76.65%23.35%Net SellingNet Selling
BCRX83.90%16.10%Net SellingNet Selling
TSHA89.69%10.31%Net BuyingNet Buying
PHVS89.05%0.00%
ATAI12.02%25.40%Net Buying
View Top Biotech Stocks

Agios Pharmaceuticals Stock Ownership FAQ

Who owns Agios Pharmaceuticals?

Agios Pharmaceuticals (NASDAQ: AGIO) is owned by 108.88% institutional shareholders, 33.18% Agios Pharmaceuticals insiders, and 0.00% retail investors. Celgene European Investment Co LLC is the largest individual Agios Pharmaceuticals shareholder, owning 5.87M shares representing 10.06% of the company. Celgene European Investment Co LLC's Agios Pharmaceuticals shares are currently valued at $160.00M.

If you're new to stock investing, here's how to buy Agios Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.